GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OCSE:NSIS B) » Definitions » Cyclically Adjusted Book per Share

Novonesis (Novozymes) B (OCSE:NSIS B) Cyclically Adjusted Book per Share : kr56.19 (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Novonesis (Novozymes) B Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Novonesis (Novozymes) B's adjusted book value per share for the three months ended in Mar. 2025 was kr179.682. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr56.19 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Novonesis (Novozymes) B's average Cyclically Adjusted Book Growth Rate was 24.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Novonesis (Novozymes) B was 9.90% per year. The lowest was 4.60% per year. And the median was 6.70% per year.

As of today (2025-07-20), Novonesis (Novozymes) B's current stock price is kr449.90. Novonesis (Novozymes) B's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr56.19. Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio of today is 8.01.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Novonesis (Novozymes) B was 13.83. The lowest was 6.23. And the median was 9.46.


Novonesis (Novozymes) B Cyclically Adjusted Book per Share Historical Data

The historical data trend for Novonesis (Novozymes) B's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Cyclically Adjusted Book per Share Chart

Novonesis (Novozymes) B Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.08 39.42 44.14 45.07 52.38

Novonesis (Novozymes) B Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.07 - 48.96 52.38 56.19

Competitive Comparison of Novonesis (Novozymes) B's Cyclically Adjusted Book per Share

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio falls into.


;
;

Novonesis (Novozymes) B Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novonesis (Novozymes) B's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=179.682/120.2000*120.2000
=179.682

Current CPI (Mar. 2025) = 120.2000.

Novonesis (Novozymes) B Quarterly Data

Book Value per Share CPI Adj_Book
201503 36.538 100.200 43.831
201506 36.524 100.300 43.771
201509 36.415 100.200 43.683
201512 38.177 99.800 45.981
201603 35.153 100.200 42.170
201606 36.448 100.600 43.549
201609 36.695 100.200 44.019
201612 39.455 100.300 47.283
201703 36.839 101.200 43.755
201706 36.132 101.200 42.916
201709 36.656 101.800 43.281
201712 38.403 101.300 45.568
201803 34.931 101.700 41.285
201806 36.856 102.300 43.305
201809 37.859 102.400 44.440
201812 39.691 102.100 46.727
201903 37.903 102.900 44.275
201906 38.626 102.900 45.120
201909 39.505 102.900 46.147
201912 40.753 102.900 47.605
202003 38.199 103.300 44.448
202006 38.557 103.200 44.908
202009 38.651 103.500 44.887
202012 40.205 103.400 46.737
202103 38.621 104.300 44.509
202106 39.297 105.000 44.986
202109 41.771 105.800 47.456
202112 42.674 106.600 48.118
202203 40.783 109.900 44.605
202206 43.802 113.600 46.347
202209 49.452 116.400 51.066
202212 49.949 115.900 51.802
202303 46.526 117.300 47.676
202306 48.313 116.400 49.890
202309 52.164 117.400 53.408
202312 50.410 116.700 51.922
202403 0.000 118.400 0.000
202406 176.857 118.500 179.394
202412 178.804 118.900 180.759
202503 179.682 120.200 179.682

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Novonesis (Novozymes) B  (OCSE:NSIS B) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=449.90/56.19
=8.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Novonesis (Novozymes) B was 13.83. The lowest was 6.23. And the median was 9.46.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Novonesis (Novozymes) B Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis (Novozymes) B Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines